Valo Health appoints Brian Alexander as CEO

Flagship Pioneering-founded Valo Health has announced the appointment of Dr Brian Alexander as its new CEO.

Additionally, Alexander will serve as Flagship Pioneering’s CEO-partner.

With 20 years of experience in biotechnology and medical leadership, he aims to enhance Valo Health’s mission to accelerate drug discovery and development.

Alexan­der said: “I am deeply honoured to join Flag­ship Pio­neer­ing and Valo Health at such a piv­otal time for the com­pa­ny. 

​“Our mis­sion at Valo is to accel­er­ate the dis­cov­ery and devel­op­ment of bet­ter medicines for patients by fun­da­men­tal­ly chang­ing the tra­di­tion­al dis­cov­ery par­a­digm, and I am excit­ed to lead and work with the amaz­ing tal­ent at Valo to deliv­er mean­ing­ful advance­ments for patients using the pow­er of AI and human-cen­tric data.”

His previous roles include CEO of Foundation Medicine and senior vice-president of research and development and head of Boston Roche Innovation Center for Roche/Genentech.

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

View profiles in store

Company Profile – free sample

Your download email will arrive shortly

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData

Tick here to opt out of curated industry news, reports, and event updates from Pharmaceutical Technology.

Submit and download

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

At Foundation Medicine, Alexander utilised molecular information to enhance cancer care and clinical decision-making.

Meanwhile, he focused on clinical development at Roche/Genentech, with machine learning, data science, and AI utilisation.

Earlier, he co-founded the Global Coalition for Adaptive Research to expedite treatment discovery and development for rare diseases through clinical trials.

Alexander was also the Harvard/MIT Center for Regulatory Science’s founding director.

At Harvard Medical School, he served as an associate professor and was a radiation oncologist at the Dana-Farber Cancer Institute and Brigham and Women’s Hospital.

Valo and Flag­ship Pio­neer­ing gen­er­al part­ner and exec­u­tive chair Paul Bion­di said: “I am delight­ed to wel­come Bri­an Alexan­der as the CEO of Valo Health and a Flag­ship Pio­neer­ing CEO-part­ner. 

​“Brian’s proven lead­er­ship across biotech­nol­o­gy makes him well-posi­tioned to guide Valo into its next chap­ter of growth, as it har­ness­es AI-dri­ven tech­nol­o­gy and high-qual­i­ty patient data to dis­cov­er and devel­op life-chang­ing medicines.”

Sign up for our daily news round-up!

Give your business an edge with our leading industry insights.